Valeria Buccheri

7PUBLICATIONS
48CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyCardiology (incl. cardiovascular diseases)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 13, 2025
Randomized, Placebo-Controlled, Triple-Blind Clinical Trial of Ivabradine for the Prevention of Cardiac Dysfunction During Anthracycline-Based Cancer Therapy.

Stephanie Itala Rizk, Isabela Bispo Santos da Silva Costa, Cecília Beatriz Bittencourt Viana Cruz

|Oct 17, 2024
External validation and calibration of the HoLISTIC Consortium's advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the Brazilian Hodgkin lymphoma registry.

Valeria Buccheri, Frederico Rafael Moreira, Irene Biasoli

|Sep 02, 2022
Lower access to risk stratification tests and drugs, and worse survival of chronic lymphocytic leukaemia patients treated in public as compared to private hospitals in Brazil: A retrospective analysis of the Brazilian registry of chronic lymphocytic leukaemia.

Verena Pfister, Fernanda de Morais Marques, Flavia Parra

|Oct 13, 2021
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma.

Pier Luigi Zinzani, Radhakrishnan Ramchandren, Armando Santoro

|Sep 04, 2020
Rescue of chemorefractory classical Hodgkin lymphoma with nivolumab and autologous stem-cell transplantation: Real-life experience.

Valeria Buccheri, Giancarlo Fatobene, Fernanda M Santos

|Apr 16, 2020
Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience.

Wellington Fernandes da Silva, Lidiane Inês da Rosa, Fernanda Salles Seguro

Pageof 2

Frequent Collaborators

1 joint publications

Wellington Fernandes da Silva

1 joint publications

Fernanda Salles Seguro

1 joint publications

Douglas Rafaele Almeida Silveira

1 joint publications

Israel Bendit